| dc.contributor.author | Majidi, S | |
| dc.contributor.author | Sehrig, FZ | |
| dc.contributor.author | Samiei, M | |
| dc.contributor.author | Milani, M | |
| dc.contributor.author | Abbasi, E | |
| dc.contributor.author | Dadashzadeh, K | |
| dc.contributor.author | Akbarzadeh, A | |
| dc.date.accessioned | 2018-08-26T07:41:07Z | |
| dc.date.available | 2018-08-26T07:41:07Z | |
| dc.date.issued | 2016 | |
| dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47411 | |
| dc.description.abstract | Gene therapy is defined as the direct transfer of genetic material to tissues or cells for the treatment of inherited disorders and acquired diseases. For gene delivery, magnetic nanoparticles (MNPs) are typically combined with a delivery platform to encapsulate the gene, and promote cell uptake. Delivery technologies that have been used with MNPs contain polymeric, viral, as well as non-viral platforms. In this review, we focus on targeted gene delivery using MNPs. | |
| dc.language.iso | English | |
| dc.relation.ispartof | ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | |
| dc.subject | cell uptake | |
| dc.subject | gene therapy | |
| dc.subject | magnetic nanoparticles | |
| dc.subject | non-viral platforms | |
| dc.title | Magnetic nanoparticles: Applications in gene delivery and gene therapy | |
| dc.type | Review | |
| dc.citation.volume | 44 | |
| dc.citation.issue | 4 | |
| dc.citation.spage | 1186 | |
| dc.citation.epage | 1193 | |
| dc.citation.index | Web of science | |
| dc.identifier.DOI | https://doi.org/10.3109/21691401.2015.1014093 | |
